Cymabay Therapeutics Insider Trades

CBAY

Track insider trading activity from Cymabay Therapeutics executives and directors. See which insiders are buying and selling CBAY stock.

Trades Last 12 Months

CBAY Price

All Insider Trades for Cymabay Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Loewy Caroline M Director
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.21M 283,460 shares
$32.48
$32.48
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.5M 323,450 shares
$32.48
$32.48
Wiggans Thomas G Director
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.18M 67,000 shares
$32.48
$32.48
Dickinson Klara Chief Regulatory Officer
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$42.9M 1,322,111 shares
$32.48
$32.48
Dorling Janet Director
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.23M 161,010 shares
$32.48
$32.48
Emster Kurt Von Director
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$292k 9,000 shares
$32.48
$32.48
Shantharam Harish Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$14.8M 454,875 shares
$32.48
$32.48
Shah Sujal Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$134M 4,122,231 shares
$32.48
$32.48
Quinlan Paul T General Counsel
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$23.1M 711,406 shares
$32.48
$32.48
Mcwherter Charles President Of R&d
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$55.9M 1,720,350 shares
$32.48
$32.48
Lefebvre Eric Director
Holding Value $0 0 shares
Last Trade
Mar 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5M 154,010 shares
$32.48
$32.48
Menold Daniel Vice President, Finance
Holding Value $4.39M 135,109 shares
Last Trade
Jan 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$242k 10,000 shares
$24.23
$32.48
Holding Value $30.9k 950 shares
Last Trade
Sep 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.4k 1,200 shares
$17.00
$32.48
Mc Wherter Charles President Of R&d
Holding Value $38.3k 1,178 shares
Last Trade
Jul 18, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.77k 236 shares
$11.72
$32.48
Kim Dennis D Chief Medical Officer
Holding Value $650k 20,000 shares
Last Trade
Apr 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$69.9k 7,781 shares
$8.98
$32.48
Stuart Lewis J Chief Commercial Officer
Holding Value $6.98M 215,000 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 215,000 shares
$7.80
$32.48
Truex Paul F Director
Holding Value $1.04M 32,000 shares
Last Trade
Jan 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 32,000 shares
$5.78
$32.48
Von Emster Kurt Director
Holding Value $1.6M 49,245 shares
Last Trade
May 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$199k 49,245 shares
$4.05
$32.48
Goldfischer Carl Director
Holding Value $0 0 shares
Last Trade
Feb 07, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.2k 2,335 shares
$9.06
$32.48
Booth Robert F. Director
Holding Value $900k 27,705 shares
Last Trade
Jan 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234k 27,705 shares
$8.43
$32.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up